Alaunos Therapeutics(us:TCRT)

    1.96

    -2.97%

    Updated on 2024-12-22

    Open:2.02
    Close:1.96
    High:2.04
    Low:1.95
    Pre Close:2.02
    Volume:9701.00
    Amount:19231.30
    Turnover:0.61%
    Shares:1.60M
    MarketCap:3.14M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30542389761.49%10619
    2024-03-3187231922714.48%8669
    2023-12-319627456781.14%91039
    2023-09-3010648599042.02%61244
    2023-06-301126624561227.53%62041
    2023-03-311217001561429.10%62447
    2022-12-311447755637932.26%242255
    2022-09-301407429341434.37%193448
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Msd Partners, L.P.10101016.31%-51-0.01%
    2024-03-31Vanguard Group Inc6291483.93%-134-0.02%
    2024-03-31Blackrock Inc.2224401.39%-32-0.01%
    2024-03-31Geode Capital Management, Llc1504170.94%-14-0.01%
    2024-03-31State Street Corp503310.31%-7-0.01%
    2024-03-31Osaic Holdings, Inc.336290.21%-3484-9.39%
    2024-03-31Northern Trust Corp290340.18%-6-0.02%
    2024-03-31Magnolia Capital Advisors Llc246950.15%-2073-7.74%
    2024-03-31Morgan Stanley170950.11%7774.76%
    2024-03-31Allred Capital Management, Llc168660.11%-2-0.01%

    About

    ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
    Address:Navy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor

    Market Movers